Symbol
Liquidia Technologies, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$18.02
Current price of the stock
$1M
Trading volume of the stock
$1.4B
Market capitalization of the company
Small Cap
Category of market capitalization
35.50%
Long-term growth mean estimate
4.50
Mean analyst rating
70.37%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
6.33
Current ratio
64.82%
Gross profit margin
-656.23%
Operating profit margin
-656.23%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-520.57%
Pretax profit margin
-520.57%
Net profit margin
-20.95%
Measures profitability relative to shareholders' equity
-22.39%
ROE excluding intangible assets
-9.16%
Measures profitability relative to total assets
-20.95%
Measures profitability relative to invested capital
0.02
Asset turnover ratio
41.18
Inventory turnover ratio
1.06
Receivables turnover ratio
85.02
Average number of days it takes to collect receivables
-10.99
Measures valuation relative to earnings
-13.06
P/E based on future earnings estimates
90.41
Measures valuation relative to sales
13.79
Measures valuation relative to book value
-7.16
Measures valuation relative to operating cash flow
-6.88
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
